Abstract
ObjectivesTo know the sources by which patients with rheumatic diseases treated with subcutaneous (SC) biological drugs obtain information on their treatment, their satisfaction with the information received from the hospital...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have